Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
NCT01581866
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Ziprasidone Hydrochloride
Sponsor
Dr. Reddy's Laboratories Limited